These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 32010079)

  • 1. Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements.
    Yu DS; Weng TH; Hu CY; Wu ZG; Li YH; Cheng LF; Wu NP; Li LJ; Yao HP
    Front Microbiol; 2019; 10():2975. PubMed ID: 32010079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements.
    Yu DS; Weng TH; Hu CY; Wu ZG; Li YH; Cheng LF; Wu NP; Li LJ; Yao HP
    Front Microbiol; 2018; 9():2724. PubMed ID: 30483236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40.
    Yu DS; Weng TH; Shen L; Wu XX; Hu CY; Wang FXC; Wu ZG; Wu HB; Wu NP; Li LJ; Yao H
    Cell Physiol Biochem; 2018; 50(3):1055-1067. PubMed ID: 30355918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rapid Screen for Host-Encoded miRNAs with Inhibitory Effects against Ebola Virus Using a Transcription- and Replication-Competent Virus-Like Particle System.
    Wang Z; Li J; Fu Y; Zhao Z; Zhang C; Li N; Li J; Cheng H; Jin X; Lu B; Guo Z; Qian J; Liu L
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
    Leske A; Waßmann I; Schnepel K; Shifflett K; Holzerland J; Bostedt L; Bohn P; Mettenleiter TC; Briggiler AM; Brignone J; Enria D; Cordo SM; Hoenen T; Groseth A
    Antiviral Res; 2019 Mar; 163():106-116. PubMed ID: 30668977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and Optimization of a Green Fluorescent Protein-Expressing Transcription and Replication-Competent Virus-Like Particle System for Ebola Virus.
    Schmidt ML; Tews BA; Groseth A; Hoenen T
    J Infect Dis; 2018 Nov; 218(suppl_5):S360-S364. PubMed ID: 30053054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.
    Biedenkopf N; Hoenen T
    Methods Mol Biol; 2017; 1628():119-131. PubMed ID: 28573615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.
    Boehmann Y; Enterlein S; Randolf A; Mühlberger E
    Virology; 2005 Feb; 332(1):406-17. PubMed ID: 15661171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVΔG/EBOVgp).
    Barrenas F; Green RR; Thomas MJ; Law GL; Proll SC; Engelmann F; Messaoudi I; Marzi A; Feldmann H; Katze MG
    Clin Vaccine Immunol; 2015 Mar; 22(3):354-6. PubMed ID: 25589554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
    Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
    Kibuuka H; Berkowitz NM; Millard M; Enama ME; Tindikahwa A; Sekiziyivu AB; Costner P; Sitar S; Glover D; Hu Z; Joshi G; Stanley D; Kunchai M; Eller LA; Bailer RT; Koup RA; Nabel GJ; Mascola JR; Sullivan NJ; Graham BS; Roederer M; Michael NL; Robb ML; Ledgerwood JE;
    Lancet; 2015 Apr; 385(9977):1545-54. PubMed ID: 25540891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus.
    McCarthy SD; Majchrzak-Kita B; Racine T; Kozlowski HN; Baker DP; Hoenen T; Kobinger GP; Fish EN; Branch DR
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004364. PubMed ID: 26752302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of the Ebola Virus Proteins VP40 and GP
    Rizk MG; Basler CF; Guatelli J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.
    Favier AL; Gout E; Reynard O; Ferraris O; Kleman JP; Volchkov V; Peyrefitte C; Thielens NM
    J Virol; 2016 Jun; 90(11):5256-5269. PubMed ID: 26984723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody.
    Wang Y; Liu Z; Dai Q
    Virus Res; 2014 Aug; 189():254-61. PubMed ID: 24930448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Screening and identification of nucleocapsid protein-nanobodies that inhibited Newcastle disease virus replication in DF-1 cells.
    Fan W; Ji P; Sun X; Kong M; Zhou N; Zhang Q; Wang Y; Liu Q; Li X; Zhou EM; Zhao Q; Sun Y
    Front Microbiol; 2022; 13():1045834. PubMed ID: 36386623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectivity-enhancing antibodies to Ebola virus glycoprotein.
    Takada A; Watanabe S; Okazaki K; Kida H; Kawaoka Y
    J Virol; 2001 Mar; 75(5):2324-30. PubMed ID: 11160735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Emergence of Getah Virus Infection in Horse With Fever in China, 2018.
    Lu G; Ou J; Ji J; Ren Z; Hu X; Wang C; Li S
    Front Microbiol; 2019; 10():2601. PubMed ID: 31787964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual monoclonal antibody-based sandwich ELISA for detection of in vitro packaged Ebola virus.
    Zai J; Yi K; Xie L; Zhu J; Feng X; Li Y
    Diagn Pathol; 2018 Dec; 13(1):96. PubMed ID: 30567559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.